The 2013 Import and Export Market for Glycosides, Glands or Other Organs and Extracts, Antisera, Vaccines, and Similar Products in Japan
Book Details
Author(s)Icon Group International
PublisherICON Group International, Inc.
ISBN / ASINB00BCEDCF8
ISBN-13978B00BCEDCF2
MarketplaceCanada 🇨🇦
Description
On the demand side, exporters and strategic planners focusing on glycosides, glands or other organs and extracts, antisera, vaccines, and similar products in Japan face a number of questions. Which countries are supplying glycosides, glands or other organs and extracts, antisera, vaccines, and similar products to Japan? How important is Japan compared to others in terms of the entire global and regional market? How much do the imports of glycosides, glands or other organs and extracts, antisera, vaccines, and similar products vary from one country of origin to another in Japan? On the supply side, Japan also exports glycosides, glands or other organs and extracts, antisera, vaccines, and similar products. Which countries receive the most exports from Japan? How are these exports concentrated across buyers? What is the value of these exports and which countries are the largest buyers?
This report was created for strategic planners, international marketing executives and import/export managers who are concerned with the market for glycosides, glands or other organs and extracts, antisera, vaccines, and similar products in Japan. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics which appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for glycosides, glands or other organs and extracts, antisera, vaccines, and similar products for those countries serving Japan via exports, or supplying from Japan via imports. It does so for the current year based on a variety of key historical indicators and econometric models.
In what follows, Chapter 2 begins by summarizing where Japan fits into the world market for imported and exported glycosides, glands or other organs and extracts, antisera, vaccines, and similar products. The total level of imports and
This report was created for strategic planners, international marketing executives and import/export managers who are concerned with the market for glycosides, glands or other organs and extracts, antisera, vaccines, and similar products in Japan. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics which appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for glycosides, glands or other organs and extracts, antisera, vaccines, and similar products for those countries serving Japan via exports, or supplying from Japan via imports. It does so for the current year based on a variety of key historical indicators and econometric models.
In what follows, Chapter 2 begins by summarizing where Japan fits into the world market for imported and exported glycosides, glands or other organs and extracts, antisera, vaccines, and similar products. The total level of imports and










